4 views left Get unlimited views with a free account
Subscribe to GlobalData Explorer
Take your business to the next level. Explore the latest trends and actionable insights to inform business strategy and pinpoint opportunities and risks.

Number of ongoing Clinical Trials (for drugs) involving Alport Syndrome by Phase

  • Industry: Pharmaceuticals
  • Current: Other Industry Indicators

  • There are currently 31 ongoing clinical trials involving Alport Syndrome

  • Of the 31 trials,25 trials are in Phase II

  • Furthermore, 5 trials are in Phase III

Number of ongoing Clinical Trials (for drugs) involving Alport Syndrome by Phase

View as table View as graph
Published: October 2021
Source: GlobalData

The global pharmaceutical industry is steadily developing new drugs for Alport Syndrome, a genetic disorder. Asia-Pacific, North America, and Europe are the regions involved in Alport Syndrome-related drug trials. 

Alport Syndrome related clinical trial sponsors 

Reata Pharmaceuticals Inc, Shanghai Children's Hospital, Chinook Therapeutics Inc, Travere Therapeutics Inc, and Sanofi are a few notable sponsors involving Alport Syndrome. A clinical trial sponsor can be a Company, Government, Individual, or Institution. 

Related Data & Insights

Number of ongoing Clinical Trials (for drugs) involving Lysosomal Storage Disorder by Phase

Global Australia Pharmaceuticals Genetic Disorders Therapy Area
Number of ongoing Clinical Trials (for drugs) involving Asthma by Phase
Global Australia Pharmaceuticals Respiratory Therapy Area
Number of ongoing Clinical Trials (for drugs) involving Hypertrophic Cardiomyopathy by Phase
Global Australia Pharmaceuticals Cardiovascular Therapy Area

Number of ongoing Clinical Trials (for drugs) involving Neonatal Seizures by Phase

Global Australia Pharmaceuticals Central Nervous System Therapy Area

Number of ongoing Clinical Trials (for drugs) involving Focal Diabetic Macular Edema by Phase

Global Australia Pharmaceuticals Metabolic Disorders Therapy Area

Number of ongoing Clinical Trials (for drugs) involving Cardiovascular Cancer by Phase

Global Australia Pharmaceuticals Oncology Therapy Area

Related Companies

Johnson & Johnson

United States of America

Sinopharm Group Co Ltd

China

HCA Healthcare Inc

United States of America

Eli Lilly and Co

United States of America

Merck & Co Inc

United States of America

Pfizer Inc

United States of America

AbbVie Inc

United States of America

AstraZeneca Plc

United Kingdom

Novartis AG

Switzerland

Sanofi

France

Still looking?

Don’t wait - discover a universe of connected data & insights with your next search. Browse over 28M data points across 22 industries.

Explorer

Access more premium companies when you subscribe to Explorer